GETI B Overview
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.
No risks detected for GETI B from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||kr405.70|
|52 Week High||kr171.00|
|52 Week Low||kr412.00|
|1 Month Change||7.24%|
|3 Month Change||9.44%|
|1 Year Change||125.95%|
|3 Year Change||355.74%|
|5 Year Change||177.88%|
|Change since IPO||1,059.14%|
Recent News & Updates
Are Investors Undervaluing Getinge AB (STO:GETI B) By 30%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Getinge AB ( STO:GETI...
Does Getinge (STO:GETI B) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Here's Why We Think Getinge (STO:GETI B) Is Well Worth Watching
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
|GETI B||SE Medical Equipment||SE Market|
Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 58.5% over the past year.
Return vs Market: GETI B exceeded the Swedish Market which returned 37.7% over the past year.
|GETI B volatility|
|GETI B Beta||0.46|
Stable Share Price: GETI B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: GETI B's weekly volatility (4%) has been stable over the past year.
About the Company
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, and logistic automation solutions; practice-oriented monitoring systems and disposables, vascular and cardiothoracic surgery solutions, anesthesia machines, beating heart surgery solutions, ceiling supply units, connected solutions, and indicators, as well as washer-disinfectors, consumables, and IT-solutions.
Getinge Fundamentals Summary
|GETI B fundamental statistics|
Is GETI B overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GETI B income statement (TTM)|
|Cost of Revenue||kr13.97b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Jan 28, 2022
|Earnings per share (EPS)||12.09|
|Net Profit Margin||11.80%|
How did GETI B perform over the long term?See historical performance and comparison
0.7%Current Dividend Yield
Is Getinge undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GETI B (SEK405.7) is trading below our estimate of fair value (SEK562.59)
Significantly Below Fair Value: GETI B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GETI B is good value based on its PE Ratio (33.6x) compared to the Swedish Medical Equipment industry average (78.7x).
PE vs Market: GETI B is poor value based on its PE Ratio (33.6x) compared to the Swedish market (23.7x).
Price to Earnings Growth Ratio
PEG Ratio: GETI B is poor value based on its PEG Ratio (5.9x)
Price to Book Ratio
PB vs Industry: GETI B is good value based on its PB Ratio (4.7x) compared to the SE Medical Equipment industry average (5x).
How is Getinge forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GETI B's forecast earnings growth (5.7% per year) is above the savings rate (0.3%).
Earnings vs Market: GETI B's earnings (5.7% per year) are forecast to grow faster than the Swedish market (5.4% per year).
High Growth Earnings: GETI B's earnings are forecast to grow, but not significantly.
Revenue vs Market: GETI B's revenue (5.3% per year) is forecast to grow faster than the Swedish market (4.8% per year).
High Growth Revenue: GETI B's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GETI B's Return on Equity is forecast to be low in 3 years time (11.2%).
How has Getinge performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GETI B has high quality earnings.
Growing Profit Margin: GETI B's current net profit margins (11.8%) are higher than last year (10.3%).
Past Earnings Growth Analysis
Earnings Trend: GETI B's earnings have grown significantly by 41% per year over the past 5 years.
Accelerating Growth: GETI B's earnings growth over the past year (7.9%) is below its 5-year average (41% per year).
Earnings vs Industry: GETI B earnings growth over the past year (7.9%) underperformed the Medical Equipment industry 12%.
Return on Equity
High ROE: GETI B's Return on Equity (13.9%) is considered low.
How is Getinge's financial position?
Financial Position Analysis
Short Term Liabilities: GETI B's short term assets (SEK15.2B) exceed its short term liabilities (SEK1.6B).
Long Term Liabilities: GETI B's short term assets (SEK15.2B) do not cover its long term liabilities (SEK17.8B).
Debt to Equity History and Analysis
Debt Level: GETI B's debt to equity ratio (18.8%) is considered satisfactory.
Reducing Debt: GETI B's debt to equity ratio has reduced from 111.3% to 18.8% over the past 5 years.
Debt Coverage: GETI B's debt is well covered by operating cash flow (166.8%).
Interest Coverage: GETI B's interest payments on its debt are well covered by EBIT (31.5x coverage).
What is Getinge current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: GETI B's dividend (0.74%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (0.92%).
High Dividend: GETI B's dividend (0.74%) is low compared to the top 25% of dividend payers in the Swedish market (3.52%).
Stability and Growth of Payments
Stable Dividend: GETI B's dividend payments have been volatile in the past 10 years.
Growing Dividend: GETI B's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (24.8%), GETI B's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: GETI B's dividends in 3 years are forecast to be well covered by earnings (33.8% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mattias Perjos (49 yo)
Mr. Mattias Perjos has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serves as Chief Executive Officer at FlexLink Systems, Inc. Mr. Perjos has been the Dire...
CEO Compensation Analysis
Compensation vs Market: Mattias's total compensation ($USD7.74M) is above average for companies of similar size in the Swedish market ($USD2.42M).
Compensation vs Earnings: Mattias's compensation has increased by more than 20% in the past year.
Experienced Management: GETI B's management team is considered experienced (4.5 years average tenure).
Experienced Board: GETI B's board of directors are considered experienced (4.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Getinge AB's employee growth, exchange listings and data sources
- Name: Getinge AB
- Ticker: GETI B
- Exchange: OM
- Founded: 1904
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr110.500b
- Shares outstanding: 272.37m
- Website: https://www.getinge.com
Number of Employees
- Getinge AB
- Lindholmspiren 7A
- Västra Götaland County
- 417 56
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/26 21:11|
|End of Day Share Price||2021/10/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.